1. Home
  2. TDOC vs AVLN Comparison

TDOC vs AVLN Comparison

Compare TDOC & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$8.30

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$30.02

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDOC
AVLN
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
TDOC
AVLN
Price
$8.30
$30.02
Analyst Decision
Buy
Analyst Count
18
0
Target Price
$7.56
N/A
AVG Volume (30 Days)
4.3M
321.4K
Earning Date
04-29-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
N/A
Revenue This Year
$1.19
N/A
Revenue Next Year
$1.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$28.26
52 Week High
$9.77
$33.24

Technical Indicators

Market Signals
Indicator
TDOC
AVLN
Relative Strength Index (RSI) 67.51 N/A
Support Level $7.97 N/A
Resistance Level $9.70 N/A
Average True Range (ATR) 0.41 0.00
MACD 0.04 0.00
Stochastic Oscillator 95.94 0.00

Price Performance

Historical Comparison
TDOC
AVLN

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: